
Eli Lilly leads obesity drug market with strong sales and promising pipeline despite rising competition.
Eli Lilly remains a leader in the obesity drug market with its approved products Zepbound and Foundayo showing strong sales growth. New pipeline candidates like retatrutide and EloraTZP have demonstrated greater weight loss in trials, positioning the...





